Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
Chubb
Colorcon
Merck
Cerilliant
Cipla
Fuji
Queensland Health
McKesson

Generated: October 24, 2017

DrugPatentWatch Database Preview

Tripelennamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tripelennamine hydrochloride and what is the scope of tripelennamine hydrochloride patent protection?

Tripelennamine hydrochloride
is the generic ingredient in three branded drugs marketed by Nylos, Watson Labs, Novartis, Parke Davis, Anabolic, Barr, Lannett, Impax Labs, and Heather, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tripelennamine hydrochloride.

Summary for Generic Name: tripelennamine hydrochloride

US Patents:0
Tradenames:3
Applicants:9
NDAs:14
Drug Master File Entries: see list1
Bulk Api Vendors: see list40
Clinical Trials: see list2,287
Patent Applications: see list848
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tripelennamine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anabolic
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL083037-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL080744-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nylos
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL085412-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL083557-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL083625-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
PBZ
tripelennamine hydrochloride
TABLET;ORAL083149-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
PBZ-SR
tripelennamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL010533-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL085188-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL080785-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Heather
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL083989-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Chubb
US Department of Justice
Merck
Federal Trade Commission
Cerilliant
Farmers Insurance
McKinsey
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot